Catch up on the top radiology content of the past week.
|Articles|July 1, 2005
U.K. study strengthens case for breast MR screening
A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
Advertisement
A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
The investigators found MRI significantly more sensitive than mammography (77% versus 40%) in detecting breast cancers across the group of 649 women. Combining the results increased the sensitivity to 94%. MRI proved especially effective in BRCA1 mutation carriers, in whom it detected all tumors. Both techniques were needed to spot all cancers in women carrying BRCA2 mutations.
Commenting on the study, Dr. Ellen Warner, a medical oncologist at Toronto-Sunnybrook Regional Cancer Centre, said that mammography may one day be abandoned for high-risk women.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging Research Insights and New Advances in Neuroradiology
2
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
3
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
4
ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer
5